
Medicine and Health
An engineered channelrhodopsin optimized for axon terminal activation and circuit mapping
S. Hamada, M. Nagase, et al.
This groundbreaking research by Shun Hamada and colleagues unveils a novel ChR2 variant engineered to target presynaptic axon terminals, enhancing optogenetic manipulation of neural circuits. The innovative mGluR2-PA tag significantly improves accuracy in circuit mapping, enabling effective transmitter release with minimal photostimulation. Discover how this advancement could transform neural circuit research!
~3 min • Beginner • English
Related Publications
Explore these studies to deepen your understanding of the subject.